Antitumor agent-159 is a mitochondria-targeting small-molecule research compound that downregulates cardiolipin, inhibits proliferation of MDA-MB-231 cancer cells, arrests the cell cycle at sub-G1, and induces apoptosis. It has demonstrated antitumor efficacy in MDA-MB-231 xenograft models. Molecular formula: C24H36ClF3N2O3; molecular weight: 493.00 g·mol⁻¹.
- Targets mitochondria and reduces cardiolipin levels.
- Inhibits proliferation of MDA-MB-231 cancer cells.
- Arrests the cell cycle at sub-G1 and induces apoptosis.
- Demonstrated in vivo efficacy in MDA-MB-231 xenograft models.
- Intended for use in in vitro and in vivo antitumor research.
- Reported purity: 99.0% (certificate of analysis).